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MitochondriaAn increase of late Na+ current (INaL) in cardiac myocytes can raise the cytosolic Na+ concentration and
is associated with activation of Ca2+/calmodulin-dependent protein kinase II (CaMKII) and alterations of
mitochondrial metabolism and Ca2+ handling by sarcoplasmic reticulum (SR). We tested the hypothesis that
augmentation of INaL can increase mitochondrial reactive oxygen species (ROS) production and oxidation of
CaMKII, resulting in spontaneous SR Ca2+ release and increased diastolic Ca2+ in myocytes. Increases of INaL
and/or of the cytosolic Na+ concentration led to mitochondrial ROS production and oxidation of CaMKII to
cause dysregulation of Ca2+ handling in rabbit cardiac myocytes.
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Regulation of cellular sodium (Na+) and calcium (Ca2+) handling
is essential for the maintenance of normal excitation–contraction
coupling [1–3]. Cardiac Na+ channels open transiently and inactivate
rapidly, causing a large, brief peak of Na+ current that initiates the
cardiac action potential [4,5]. Under pathological conditions, including
heart failure and myocardial ischemia, Na+ channel inactivation is
slowed and/or incomplete, resulting in a sustained Na+ current,
referred to as persistent or late Na+ current (INaL) [3–5]. Increased INaL
promotes intracellular Na+ overload, thereby reducing the electro-
chemical gradient for Ca2+ extrusion by the Na+–Ca2+ exchanger
(NCX), causing cellular Ca2+ overload, contractile dysfunction, and
arrhythmias [3–5].ent of Biology, Gilead Sciences,
el.: +1 510 739 8453; fax: +1
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. This is an open access article underIn addition to increasing cytosolic Ca2+, intracellular Na+ overload
also perturbs mitochondrial Ca2+ homeostasis, resulting in mitochon-
drial reactive oxygen species (ROS) generation [6–8]. Ca2+ is an impor-
tant regulator of the mitochondrial redox state [6–10]. Ca2+ activates
key rate-limiting enzymes of the Krebs cycle (pyruvate, isocitrate, and
malate dehydrogenases) required for producing NADH (the main
electron donor for ATP in the respiratory chain) and for regenerating
NADPH (tomaintain the antioxidative capacity of mitochondrial matrix
enzymes) [9].When cardiacwork increases,mitochondrial Ca2+ uptake
is elevated to increase the Krebs cycle activity and ATP production to
meet an increased metabolic demand [9]. An elevation of the cytosolic
[Na+], on the other hand, decreases mitochondrial Ca2+ uptake and
NADH levels [6]. In myocytes isolated from failing hearts, cytosolic
Na+ elevation promotes mitochondrial Ca2+ efﬂux via the mitochon-
drial Na+–Ca2+ exchanger, and thereby reduces the Krebs cycle activity
and levels of NADH and NADPH [6,7]. A decrease in the level of NADPH
impairs the capacity of antioxidant enzymes such as thioredoxin and
glutathione to reverse protein oxidation, thus increasing ROS-induced
cellular dysfunction. Indeed, the elevated ROS in cardiomyocytes isolat-
ed from the failing heart can be normalized either by lowering cytosolic
[Na+] or by inhibitingmitochondrial Na+–Ca2+ exchange [7,8,10]. Con-
versely, elevating cytosolic Na+ increases ROS generation in normal
cardiomyocytes [7]. These studies suggest that mitochondrial ROSthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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logical effects of cytosolic Na+ overload [2,7,8,10].
Elevated ROS production promotes adverse cardiac remodeling by
activating intracellular signaling pathways that induce cardiomyocyte
cell death, hypertrophy, and arrhythmia [11]. We previously demon-
strated that the multi-functional Ca2+/calmodulin-dependent protein
kinase II delta (CaMKIIδ) is activated in response to enhanced INaL and
mediates downstream pathological processes that include necrotic
and apoptotic cardiac cell death and ventricular arrhythmia [12].
CaMKIIδ phosphorylates a number of substrates involved in cellular
Ca2+ homeostasis, including phospholamban (PLN), the sarcoplasmic
reticulum (SR) Ca2+ATPase, ryanodine receptor 2 (RyR2), and the
cardiac Na+ channel, Nav1.5. Phosphorylation of these proteins disrupts
normal SR Ca2+ cycling, promotes cellular Ca2+ overload, induces spon-
taneous Ca2+ release, and alters excitation–contraction coupling and
propagation of electrical impulses [13–18]. CaMKIIδ activity is regulated
by Ca2+/calmodulin and depends on the amplitude and frequency of
cytosolic Ca2+waves. CaMKIIδ activity is also regulated by direct oxida-
tion of methionine 281/282 at its regulatory domain [11,15]. Based on
its dual modes of activation, CaMKIIδ is centrally poised to sense eleva-
tions in either Ca2+ or ROS, and to initiate downstream molecular
events that promote Ca2+ mishandling. CaMKIIδ may therefore serve
as a nodal point of convergence for pathological signaling events
induced by an increased INaL [12,18].
Despite the well-established link between cytosolic Na+ overload
and altered intracellular Ca2+ handling [3–8,12,19–21], themechanism
of Na+-dependentmodulation of Ca2+dynamics is not fully understood
[2]. In this study we tested the hypothesis that intracellular Na+ over-
load caused by an enhanced INaL increases mitochondrial ROS produc-
tion, resulting in oxidation-induced activation of CaMKIIδ that in turn
promotes Ca2+ mishandling. Our experimental approaches to study
the pathway between intracellular Na+ overload and Ca2+mishandling
included intact and permeabilized adult rabbit cardiomyocytes exposed
to an enhancer of INaL and an increased superfusate Na+ concentration,
respectively, and a mouse model of pressure overload-induced heart
failure. Fluorescent dyes sensitive to Na+, Ca2+, and ROS were used to
measure the effects of increased INaL and intracellular Na+ to alter ROS
formation and cellular Ca2+ handling. Anemonia sulcata toxin II (ATX-
II) and ranolazine were used to increase and inhibit INaL, respectively
[22,4].
2. Materials and methods
2.1. Chemicals
ATX-II and tetrodotoxin were purchased from Alomone Labs and
Tocris Bioscience, respectively. Dithiothreitol (DTT) and coenzyme
Q10 (CoQ10) were purchased from Sigma Chemical. The CaMKII inhib-
itor KN-93 and its inactive analog KN-92 were purchased from EMD
Millipore. Ranolazine and the selective INaL blocker GS-967 [23] were
provided by Gilead Sciences. The sources of ﬂuorescent dyes and anti-
bodies are indicated in the relevant sections below.
2.2. Cell isolation
Experimental protocols using animals were approved by the Gilead
Institutional Animal Care and Use Committee following the criteria
outlined in the National Institutes of Health Guide for the Care and
Use of Laboratory Animals (NIH Publication No. 85-23, revised 1996).
Adult female 2–3 kg New ZealandWhite rabbits (Western Oregon Rab-
bit Company) were sedated with intramuscular injections of 35 mg/kg
ketamine and 5 mg/kg xylazine. The respiratory rate, muscle tone, and
righting reﬂex were monitored to ensure sedation. Once sedated,
rabbits were given 1 mL of heparin (1000 USP units/mL) into the ear
vein and then deeply anesthetized by intravenous injection of
15 mg/mL ketamine and 3 mg/mL xylazine. Hearts were removedand mounted on a Langendorff apparatus for retrograde perfusion
(17–20 mL/min) of the aorta with a perfusion solution containing (in
mmol/L): 140 NaCl, 4.4 KCl, 1.5 MgCl2, 1 NaH2PO4, 5 HEPES, 7.5 glucose,
16 taurine, 5 Na pyruvate, and NaOH to adjust the pH to 7.3. Cardiac
myocytes were enzymatically isolated from left ventricles as previously
described by Brunner et al. [24]. The perfusion solution was supple-
mented with collagenase type II enzyme (0.8 mg/mL, Worthington),
0.2% 2,3-butanedione monoxime, and 0.2% bovine serum albumin. Left
ventricles were dissected, chopped, and subjected to postdigestion in
a shaker with periodical changes of an isolation solution. The isolation
solution contained (in mmol/L): 140 NaCl, 4.6 KCl, 1.1 MgCl2, 1
NaH2PO4, 10 HEPES, 10 glucose, and NaOH to adjust the pH to 7.4. The
isolation solution was supplemented with a low concentration
(0.344 mg/mL) of collagenase and 0.975% albumin. All procedures
were performed at 37 °C. Isolated cardiomyocytes were used within
6 h after isolation.
Adult malemicewere heparinized and sacriﬁced by cervical disloca-
tion. The hearts were perfused on the Langendorff apparatus with
the following solution (in mmol/L): 135 NaCl, 4.6 KCl, 1.1 MgCl2, 1
NaH2PO4, 10 HEPES, 10 glucose, and NaOH to adjust the pH to 7.4.
Then hearts were perfused with a solution supplemented with
0.896 mg/mL collagenase, 0.08 mg/mL protease type XIV, and
0.68mg/mL bovine serum albumin for 15–20min at 29 °C. The left ven-
tricles were dissected and gently triturated. Isolated cardiomyocytes
were used within 4 h after isolation.
2.3. Patch-clamp experiments
Thewhole-cell conﬁguration of the patch-clamp techniquewas used
to record INa in the voltage-clampmode using aMulticlamp700B ampli-
ﬁer (Molecular Devices) and pClamp 10.2 data acquisition software
(Molecular Devices). The digital data were analyzed using pClampﬁt
10, Microcal Origin (OriginLab), and GraphPad Prism (Graph Pad Soft-
ware) programs. Patch pipettes were pulled from a borosilicate glass
(World Precision Instruments) using a DMZ Universal puller (Dagan).
For the recording of INa, cardiomyocytes were superfused with a bath
solution containing (in mM): 135 NaCl, 4.6 CsCl, 1.8 CaCl2, 1.1 MgSO4,
10 HEPES, 10 glucose, and 0.01 nitrendipine (pH 7.4 adjusted with
NaOH). Pipette resistance was 1.5–2 MΩ when ﬁlled with a pipette
(internal) solution containing (in mM): 120 aspartic acid, 20 CsCl, 1
MgSO4, 4 ATPNa2, 0.1 GTPNa3, and 10 HEPES (pH 7.3 adjusted with
CsOH). The recordings of INa were performed at 22–24 °C following a
stabilization period (5–10 min) after establishing a patch with whole-
cell conﬁguration. The myocytes were held at −120 mV and
depolarizing pulses (−20 mV, 220 ms) were applied at a rate of 1 Hz.
The rate of decay (inactivation) of INa was ﬁtted using two exponential
terms, and the slower component was used to describe INaL.
2.4. Measurement of intracellular dye ﬂuorescence
Experiments were performed using a LSM 5 PASCAL (Carl Zeiss)
laser scanning confocal system equipped with a Zeiss Plan-
Apochromat 40× 1.4 numerical aperture oil immersion objective.
Myocytes were maintained in a bath solution containing (in mmol/L):
140 NaCl, 5.4 KCl, 2.0 CaCl2, 2.5 MgCl2, 10 HEPES and 5.6 glucose,
pH 7.3. Cells were incubated for 25 min at 23 °C in the bath solution
supplemented with 0.25 mmol/L CaCl2, 2.5 μmol/L pluronic acid (Life
Technologies) and the appropriate ﬂuorescent dye, either 5 μmol/L
Fluo-4 AM (Life Technologies), 5 μmol/L Asante NaTRIUM Green
AM, Asante NaTRIUM Green-2 AM (Teﬂabs), 10 μmol/L 2′,7′-
dichloroﬂuorescein diacetate (DCFDA; Life Technologies), or 2 μmol/L
MitoSOX Red (Life Technologies). Myocytes were permeabilized as
previously described [25], using saponin (0.01%) added to a solution
containing (in mmol/L): 120 K+ L-aspartate, 20 KCl, 3 MgATP, 10 phos-
phocreatine, 1 KH2PO4, 5 NaCl, 0.1 EGTA, 0.7 MgCl2, 0.019 CaCl2, 20
HEPES (pH 7.2), 5 units/mL creatine phosphokinase, and 5 μmol/L
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tion was calculated using MAXChelator software (Stanford University).
Fluo-3, Fluo-4, DCFDA, and MitoSOX Red were excited at 488 nm,
and ﬂuorescence signals were acquired at wavelengths N505 nm in
the line scanmode or XYmode of the confocal system. Asante NaTRIUM
Green and Asante NaTRIUM Green 2 were excited at 543 nm, and ﬂuo-
rescence was acquired at wavelengths N560 nm in the XY scan mode.
Fluorescent images were analyzed using ImageJ software (NIH) and
Origin 8.1 (OriginLab).
We used exogenous CaMKII (New England Biolabs) to potentiate
Ca2+ signals in membrane-permeabilized cardiomyocytes [26]. CaMKII
was pre-activated by incubation at 30 °C in a CaMKII reaction buffer
supplemented with 100 μmol/L ATP, 1.2 μmol/L calmodulin, and
2 mmol/L CaCl2 for 10 min.
In the experiments on intact cells, myocytes were paced at 1 Hz.
Fluorescent signals were recorded after 2 min of pacing before or after
drug application. For experiments using membrane-permeabilized
cells, ﬂuorescence images were recorded within 5 min after membrane
permeabilization. All measurements were done at a temperature of 22–
24 °C.
2.5. Western blot analysis
Western blot analyses were performed by a standard method.
Antibodies for phospho-CaMKIIδ at threonine 286 and for GAPDH
were purchased from Santa Cruz Biotechnology. Antibodies for PLN
phosphorylated at threonine 17 and RyR2 phosphorylated at serine
2814 were purchased from Badrilla. To detect oxidized CaMKIIδ, an
immune serum with antibodies directed against oxidized M281/M282
(ox-CaMKII) was used (polyclonal rabbit, 1:2500 dilution). Secondary
antibody was horseradish peroxidase-linked goat anti-rabbit (1:1000)
(PerkinElmer Life and Analytical Sciences). The relative intensity of
individual bands fromWestern blotswas quantitated using ImageJ soft-
ware and normalized to GAPDH. The ratio for control was assigned a
value of 1.
2.6. TAC mouse model of HF
Transverse aortic constriction (TAC)was performed on 3-month-old
male CD-1 mice as previously described [27]. The presence of a TAC-
induced pressure gradient across the aortic constriction was veriﬁed
using echocardiography. Serial echocardiography was done for data
acquisition. Two-dimensional guided m-mode and 2D images were
used to quantify and estimate LV luminal dimensions, systolic and
diastolic functions, and fractional shortening. Only mice with an aortic
pressure gradient N30 mm Hg were used for experiments. Sham-
operated animals were used as controls.
2.7. Statistics
All values were expressed as mean ± SEM. Statistical comparisons
were made using unpaired Student's t-test or 2-way ANOVA for repeat-
ed measurements (p b 0.05).
3. Results
3.1. ATX-II increases INaL in adult rabbit ventricular myocytes
To increase INaL in rabbit ventricular myocytes, we superfused cells
with 5 nM ATX-II for 30 min. Treatment with ATX-II caused a slowing
of the rate of decay of Na+ current induced by a depolarizing voltage-
clamp pulse, thereby increasing INaL (Fig. 1A). The time constants of
INa decay were 84.6 ± 9.5 ms in ATX-II treated cells and 47.8 ± 9.1 ms
in control (vehicle-treated) cells. These results are consistent with
previous ﬁndings that ATX-II causes slowing and incomplete inactiva-
tion of Na+ channels, and increased INaL [12,19,28].3.2. ATX-II increases Na+ and ROS production, and causes Ca2+
mishandling in rabbit ventricular myocytes
The INaL enhancer ATX-II markedly increased the intracellular Na+
concentration measured with the ﬂuorescent dye Asante NaTRIUM
Green in cardiomyocytes paced at a rate of 1 Hz. The value of F/F0, the
intensity of dye ﬂuorescence in the presence of ATX-II normalized to
that before pacing and drug application, was 1.38 ± 0.04 (Fig. 1Bi and
Ci). Treatment with the late Na+ current blockers ranolazine
(10 μmol/L), tetrodotoxin (1 μmol/L), andGS-967 (1 μmol/L) in thepres-
ence of ATX-II reduced the values of F/F0 to 1.16 ± 0.06, 1.18 ± 0.09,
and 1.1 ± 0.04, respectively (Fig. 1Ci).
ATX-II also signiﬁcantly increased the cytosolic ROS level (Fig. 1Bii
and Cii). The F/F0 value of DCFDA ﬂuorescence was signiﬁcantly
increased from 1.02 ± 0.04 in control to 1.15 ± 0.02 in the presence
of ATX-II (Fig. 1Cii). Application of ranolazine, TTX or GS-967 signiﬁ-
cantly reduced cellular ROS production in the presence of ATX-II (F/F0
values were 1.05 ± 0.03, 1.06 ± 0.06 and 1.05 ± 0.05, respectively).
Line-scan confocal images of cardiomyocytes loadedwith Fluo-4 AM
and paced at 1 Hz revealed an increase in the diastolic Ca2+ level in the
presence of ATX-II. The value of F/F0 was increased from 1.0 ± 0.01 in
control to 1.78± 0.09 in the presence of ATX-II (Fig. 1Biii and Ciii). Inhi-
bition of Na+ inﬂux with ranolazine, TTX or GS-967 signiﬁcantly de-
creased the diastolic Ca2+ level in the presence of ATX-II; the values of
F/F0 were 1.16 ± 0.06 (RAN), 1.19 ± 0.09 (TTX) and 1.09 ± 0.07 (GS-
967), respectively (Fig. 1Ciii). ATX-induced spontaneous arrhythmic
Ca2+ releases was also blocked by ranolazine (see Ca2+ transients in
Fig. 1Biii).
3.3. Both ROS production and CaMKIIδ activation are essential for ATX-II-
induced abnormal intracellular Ca2+ handling
To determine whether intracellular Ca2+ mishandling depends on
Na+-induced oxidative stress, we applied antioxidants to ATX-II-treated
rabbit cardiomyocytes (Fig. 2A, B). ATX-II alone increased the number
of Ca2+ transients and the diastolic Ca2+ level (Fig. 2A, B). ATX-II also in-
creased the rate of leak of Ca2+ from the SR (Supplemental Fig. 1). Either
dithiothreitol (DTT, 5 mmol/L) or coenzyme Q10 (CoQ10, 10 μmol/L)
signiﬁcantly attenuated an ATX-II-induced increase in diastolic Ca2+
concentration, restoredCa2+ transient amplitude, and eliminated cellular
arrhythmias (Fig. 2A, B). CoQ10 also reduced cytosolic Na+ levels in
ATX-II-treated cardiomyocytes (Supplemental Fig. 2).
Nextwe determinedwhether CaMKIIδ is involved in ATX-II-induced
Ca2+mishandling. Application of a CaMKII inhibitor, either autocamtide
inhibitory peptide (AIP, 1 μmol/L) or KN-93 (3 μmol/L), improved intra-
cellular Ca2+ handling in ATX-II-treated cells (Fig. 2A, B). By contrast,
KN-92, a non-active analog of KN-93, had no effect. Western blot anal-
ysis revealed an increase in oxidation of CaMKIIδ at Met281/282
and autophosphorylation of CaMKIIδ at Thr287 (Fig. 2C, D) in the
presence of 5 nmol/L ATX-II (Fig. 2C). Antioxidants DTT and CoQ10
prevented the oxidation and phosphorylation of CaMKII in ATX-II-
treated cells (Fig. 2C, D). The effect of KN-93 (but not KN-92) was
similar to that of the antioxidants. Furthermore, DTT, CoQ10 and
KN-93 reduced phosphorylations of CaMKIIδ targets, RyR2 at serine
2814 and PLN at serine 17 (Fig. 2C, D), in the presence of ATX-II.
These results suggest that ATX-II-induced ROS production may activate
CaMKII.
3.4. Elevated Na+ modulates Ca2+ handling in membrane-permeabilized
cardiomyocytes
To rule out the possibility that ion channels, Ca2+ pumps and NCX in
the sarcolemmal membrane may explain the effects of ATX-II and in-
creased cytosolic [Na+]i on intracellular Ca2+ handling in this study,
we used membrane-permeabilized cardiomyocytes that allow us to
control cytosolic Na+ and Ca2+ concentrations. We clamped the
Fig. 1.Activation of INaL byATX-II in rabbit ventricularmyocytes. i) Representative recordings of INaL in the absence of drug (control) and after superfusionwith 5 nMATX-II. ii)Mean values
of INaL decay time constant in control and after superfusion with 5 nM ATX-II (N = 4). B. Confocal images of a rabbit ventricular myocyte paced at 1 Hz and loaded with Na+ dye Asante
NaTRIUMGreen AM. (i). Application of ATX-II for 2min increased cytosolic Na+ compared to control (Ctrl). This effect was reversed by ranolazine (RAN, 10 μmM). ii) Cytosolic ROS,mea-
sured using DCFDA, was increased in response to ATX-II, and was also reduced by treatment with RAN. iii) Line-scan recordings of Ca2+ transients using the dye Fluo-4 AM. ATX-II in-
creased spontaneous Ca2+ release and increased diastolic Ca2+ level (shown in blue under each Ca2+ transient proﬁle). ATX-II effects on Ca2+ transients were reversed by RAN.
C. Quantiﬁcation of results for ATX-II-induced changes in i) cytosolic Na+, ii) cytosolic ROS, and iii) diastolic Ca2+ levels in the absence and presence of RAN (10 μM), TTX (1 μM) and
GS-967 (1 μM). Data are normalized to F0 — the baseline ﬂuorescence signal at the beginning of an experiment. N = 3–14, *p b 0.05 vs control; †p b 0.05 vs ATX-II.
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In the presence of 5 mmol/L Na+, a rhythmic pattern of spontaneous
Ca2+ transients is observed in membrane-permeabilized myocytes
(Fig. 3A and reference [25]). Elevation of the intracellular Na+ concen-
tration from a physiological (5 mmol/L) to a pathological (20 mmol/L)
level resulted in an accelerated rate of spontaneous Ca2+ waves
(Fig. 3A). The presence of CoQ10 prevented such an acceleration
(Fig. 3B). The ﬁnding suggests that ROS plays a role in activation of
Ca2+ release from intracellular stores (e.g., sarcoplasmic reticulum)
when the intracellular Na+ concentration is raised. Activation of CaMKII
by ROS is a potentialmechanismof the effect. To verify the involvement of
CaMKII in the response to 20 mmol/L Na+, we pre-treated cells with the
CaMKII inhibitor KN-93 (3 μmol/L). KN-93 (but not KN-92) abolished
acceleration of spontaneous Ca2+ waves induced by 20 mmol/L Na+
(Fig. 3C). As positive controls, permeabilized myocytes were incubated
with exogenous pre-activated CaMKII (2 units activity/mL) or H2O2
(100 μmol/L); these agents also induced an acceleration of the frequency
of spontaneous Ca2+ releases (Supplemental Figs. 3 and 4).
An increase in intracellular Na+ can cause Ca2+ efﬂux from mito-
chondria, and has the potential to increase mitochondrial ROS produc-
tion. Therefore, we used the mitochondria-speciﬁc ROS indicator
MitoSOX Red to assess ROS production in mitochondria in membrane-
permeabilized cardiomyocytes exposed to 5 and 20 mmol/L Na+. The
ﬂuorescence of MitoSOX Redwas increased to 173± 15% of initial ﬂuo-
rescence intensity in response to elevation of Na+ from 5 to 20 mmol/L(Supplemental Fig. 5). Inhibition of mitochondrial Na+–Ca2+ exchange
with 10 μmol/L CGP-37157 abolished the effect of 20 mmol/L Na+ on
the frequency of intracellular Ca2+ transients (Fig. 3C). These data are
in accordance with previous observations [6,10].
3.5. Na+ overload and oxidative stress in mouse TAC model of HF
To conﬁrmwhether Na+ overload can cause ROS production and in-
crease in diastolic Ca2+ in the failing heart, we isolated cardiomyocytes
from TACmicewith failing hearts. At 4 weeks after TAC, themice devel-
oped cardiac hypertrophy (a 38% increase in the ratio of heart/body
weight) and fractional shortening of LV myocardium was reduced
(Fig. 4A). It has been shownpreviously that the level of phosphorylation
of CaMKII is increased in TAC hearts [29]. To determine whether TAC
intervention changed oxidation of CaMKII we carried out Western blot
analysis, which showed a signiﬁcant increase in ox-CaMKII in TAC cardi-
ac tissue when compared to sham tissue (Fig. 4B). The level of intracel-
lular Na+ in paced myocytes isolated from TAC animals was
signiﬁcantly reduced by ranolazine (10 μmol/L) or TTX (1 μmol/L)
(Fig. 4C) as indicated by decreases in ﬂuorescence of the Na+-
sensitive dye Asante NaTRIUM Green-2 to 74% and 78% of baseline,
respectively. Neither ranolazine nor TTX reduced dye ﬂuorescence in
myocytes isolated from sham-operated animals (Supplemental Fig. 6).
The antioxidant CoQ10 (10 μmol/L) and the CaMKII inhibitor KN-93
(3 μmol/L), but not KN-92, also signiﬁcantly decreased AsanteNaTRIUM
Fig. 2.ATX-II-inducedCa2+mishandling is reversedby antioxidants or CaMKII inhibition.A. Line-scan confocal images of Ca2+ transients recorded frompaced adult rabbit cardiomyocytes.
The antioxidants CoQ10 (10 μM) and DTT (5 mM) or the CaMKII inhibitors, AIP (1 μmM) or KN-93 (3 μM), were applied after induction of arrhythmic Ca2+ transients with 5 nM ATX-II.
Treatment with antioxidants or CaMKII inhibitors restored normal Ca2+ dynamics and attenuated arrhythmic Ca2+ transients. KN-92 (3 μM)was used as a negative control for KN-93. B.
Quantiﬁcation of i) diastolic Ca2+, and ii) number of cells with arrhythmic Ca2+ transients (%). N= 4–24; *p b 0.05 vs control; †p b 0.05 vs ATX-II alone. C.Western blots for oxidation of
CaMKII at Met281/282 (ox-CaMKII), phosphorylation of CaMKII at Thr287 (p-CaMKII), phosphorylation of RyR2s at Ser2814 (p-RyR2) and phosphorylation of PLN at Thr17 (p-PLN).
Cardiomyocytes were treated with 5 nM ATX-II, in the absence and presence of antioxidants CoQ10 (10 μM), DTT (5 mM), the CaMKII inhibitor KN-93 (3 μM) and the inactive analog,
KN-92 (3 μM). D. Western blot quantiﬁcation, normalized to GAPDH (N= 3, *p b 0.05 vs control and †p b 0.05 vs ATX-II alone).
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from TAC mice (Fig. 4C). Treatment of TAC myocytes with ranolazine
(10 μmol/L) or TTX (1 μmol/L) also signiﬁcantly decreased the ﬂuores-
cence of DCFDA (a ROS-sensitive ﬂuorescent indicator) by 72% and
80% relative to baseline, respectively (Fig. 4D). The ﬂuorescence of
DCFDA was also decreased to 69% of baseline by CoQ10 (10 μmol/L)
(Fig. 4D). However, inhibition of CaMKII with KN-93 (3 μmol/L) did
not signiﬁcantly change the ROS level (Fig. 4D). None of the studied
drugs had an effect on basal Na+ and ROS levels in myocytes isolated
from sham-operated animals (Supplemental Fig. 6).
Analysis of Ca2+ transients in myocytes isolated from sham-
operated and TAC animals indicated that the rise time of the transient
was signiﬁcantly longer in the TAC group (Supplemental Table 1). Spon-
taneous Ca2+ releases following the termination of 1-Hz stimulationsoccurred more often in myocytes from TAC than in those isolated from
sham animals (Fig. 4E). Inhibition of INaL by ranolazine (1 μmol/L) or
CaMKII with KN-93 (3 μmol/L) normalized Ca2+ transients and dimin-
ished spontaneous Ca2+ waves in TACmyocytes (Fig. 4E, Supplemental
Table I) whereas KN-92 (3 μmol/L) had no effect.
4. Discussion
The goal of the present study was to elucidate potential pathways
that connect the increases of INaL and of the cytosolic Na+ concentration
(i.e., Na+ overload) to disruption of intracellular Ca2+ storage and
release (dysfunctional Ca2+ handling). The major ﬁndings were: 1)
increases of INaL and [Na+]i promoted ROS generation, CaMKII oxidation
and phosphorylation, and phosphorylation of CaMKII substrates,
Fig. 3. Role of ROS, mitochondrial Na+–Ca2+ exchange, and CaMKII in maladaptive Ca2+ handling induced by elevation of [Na+]i in membrane-permeabilized cardiomyocytes: A.
i) Confocal line-scan image and proﬁle of Ca2+ transients in amembrane-permeabilized rabbit ventricularmyocyte, recorded during elevation of cytosolic Na+ from 5 to 20mM; ii) spon-
taneous Ca2+wave frequency and iii) diastolic Ca2+ level for the experiment shown in panel (i). B. i. Confocal line-scan image and proﬁle of Ca2+ transients in amembrane-permeabilized
rabbit ventricular myocyte during elevation of cytosolic Na+ from 5 to 20mM in the presence of the antioxidant CoQ10 (10 μmM); ii) spontaneous Ca2+wave frequency and iii) diastolic
Ca2+ level for the experiment shown in (i). C. Quantiﬁcation of spontaneous Ca2+wave frequency f/f0 (i) and the diastolic Ca2+ level (ii), induced by elevation of [Na+]i in the absence and
presence of the antioxidant CoQ10 (10 μM), theCaMKII inhibitor KN-93 (3 μM), the inactive analog KN-92 (3 μM)ormitochondrial Na+–Ca2+ exchange inhibitor CGP-37157 (CGP, 10 μM)
N = 4–10, *p b 0.05 vs control; †p b 0.05 vs 20 mM Na+. f0, the frequency of spontaneous Ca2+ waves at the beginning of the experiment.
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Ca2+ and the frequency of spontaneous Ca2+ waves in membrane-
permeabilized myocytes, i.e., in the absence of sarcolemmal membrane
regulation of the intracellular Ca2+ concentration; 3) Ca2+mishandling
induced by Na+ overload was reversed by ranolazine and tetrodotoxin,
CaMKII inhibitors, antioxidants, and inhibition of the mitochondrial
Na+–Ca2+ exchanger; 4) in cardiomyocytes isolated from failing hearts
of TACmice, intracellular levels of Na+ and ROSwere reduced by inhib-
itors of INaL and by CoQ10, and inhibition of CaMKII reduced the
frequency of spontaneous Ca2+ release events. Taken together, the
results suggest a pathological pathway (Fig. 5) whereby cardiomyocyte
Na+ overload promotes mitochondrial ROS generation, resulting in
CaMKII oxidation and phosphorylation, and CaMKII-mediated phos-
phorylation of substrates including RyR2, which increases Ca2+ leak
from SR (Supplemental Fig. 1) and the frequency of SR Ca2+ release
events (Figs. 1, 2), resulting in an increase of the cytosolic Ca2+ concen-
tration during diastole (Figs. 1, 2, 5). This pathway appears to be opera-
tive in myocytes of failing hearts. Our ﬁndings are consistent with and
expand on the previously reported links between cytosolic Na+overload andmitochondrial ROS generation [6,7] and between oxidized
CaMKII and Ca2+ overload [2,11,12,18,30,31].
4.1. Contribution of INaL to Na
+ inﬂux
In the present researchweused INaL enhancement (Fig. 1) as a tool to
increase cytosolic Na+ load. INaL that occurs during the plateau of the
action potential has been shown by many investigators to cause AP
prolongation. INaL can account for 30% or more of Na+ inﬂux through
myocyte Na+ channels [32]. Other potential sources of Na+ entry via
Na+ channels are “window current” [33], and “background current”
near the threshold of Na+ channel activation [34]. They are not usually
called INaL, which typically refers to current at plateau potentials due to
failure of open state inactivation of Na+ channels, but they can be
blocked by ranolazine and TTX and may have contributed to Na+
entry in this study. The effects of CaMKII, oxidation, and diseases on
window and background Na+ currents are poorly understood.
Our results indicate that the decay time constant of INaL in ATX-II
(5 nM)-treated rabbit cardiomyocytes was prolonged 1.5–2-fold. This
Fig. 4. Pathological contributions of INaL, CaMKII and ROS to maladaptive Ca2+ handling in cardiomyocytes isolated from mouse failing hearts. A. i) Heart weight/body weight ratio and
ii) fractional shortening (FS, %) of the left ventricular wall inmale CD-1mice subjected to transverse aortic constriction (TAC) for 4 weeks, compared to sham-operated, age-matched con-
trols (sham). B. i)Western blots for oxidation of CaMKII at Met281/282 (ox-CaMKII) andWestern blot quantiﬁcation, normalized to GAPDH (ii). Effects of ranolazine (10 μM), TTX (1 μM),
CoQ10 (10 μM), KN-93 (3 μM), and KN-92 (3 μM) on levels of intracellular Na+ (C) and ROS (D) in myocytes isolated from TAC mice and paced at a rate of 1 Hz (N = 3–20, p b 0.05),
compared to baseline. E. Spontaneous Ca2+ release events following termination of 1 Hz stimulation of myocytes isolated from sham-operated and TAC mice in the absence or presence
of RAN (10 μM), KN-93 (3 μM) or its inactive analog KN-92 (3 μM). *p b 0.05 vs sham and †p b 0.05 vs TAC without drugs.
Fig. 5. Proposed mechanism for INaL-mediated Na+ overload-induced disruption of
myocyte Ca2+ handling. An increase of INaL leads to an increase of [Na+]i. Cytosolic Na+
overload attenuatesmitochondrial Ca2+ uptake via themitochondrial Na+/Ca2+ exchang-
er, thereby reducingNADPH regeneration and increasingmitochondrial ROS. ROS oxidizes
and activates CaMKII, resulting in phosphorylation of the CaMKII substrate RyR2 and
increasing Ca2+ leak from sarcoplasmic reticulum (SR).
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failing hearts in TAC mice [29]. This suggests that the increase of INaL is
comparable in both models. Therefore, we believe that the effect of
ATX-II on rabbit myocytes in this study is not so large as to be irrelevant
to an understanding of its potential pathological effects in failing hearts,
and to themechanisms by which the effect of Na+ overload (regardless
of its cause) is mediated.4.2. Na+ overload induced mitochondrial ROS generation
The detrimental inﬂuence of intracellular Na+ overload on cardiac
cell function is well recognized [3–5,8,12,19–21]. The prevailing view
of the pathway that connects cytosolic Na+ accumulation to altered
Ca2+ homeostasis has focused on the role of the sarcolemmal Na+–
Ca2+ exchanger in regulation of the cytosolic Ca2+ concentration. In
this pathway, Na+ overload decreases Ca2+ extrusion and increases
Ca2+ entry via the exchanger, causing Ca2+ accumulation that results
254 S. Viatchenko-Karpinski et al. / Journal of Molecular and Cellular Cardiology 76 (2014) 247–256in contractile dysfunction and arrhythmias. The results of the present
study do not dispute the validity of this mechanism. However, our
results suggest that mechanisms independent of membrane Na+–
Ca2+ exchange also appear to take part in Na+ overload-induced dys-
regulation of Ca2+ homeostasis. The ﬁnding that ATX-II, an enhancer
of INaL, increased cytosolic Na+, diastolic Ca2+, ROS, the frequency of
spontaneous Ca2+ release events, and oxidation and phosphorylation
of CaMKII strongly suggest that INaL can raise the level of cytosolic Na+
sufﬁciently to disrupt Ca2+ homeostasis. Importantly, we demonstrate
that in the absence of a functional plasma membrane (i.e., in
membrane-permeabilized adult rabbit cardiomyocytes) elevation of
cytosolic Na+ alone is sufﬁcient to provoke increases in ROS generation,
the frequency of Ca2+ waves, and the diastolic Ca2+ concentration
(Fig. 3).
Our observations that ATX-II promotes elevated ROS production
(Fig. 1) and that deleterious consequences of Na+ overload are attenu-
ated by antioxidants such as CoQ10 and DTT (Figs. 2, 3) are in agree-
ment with a growing body of evidence demonstrating that Na+
overload promotes cellular oxidative stress. Kohlhaas et al. [7] recently
described a series of experiments demonstrating that elevation of cyto-
solic Na+ is sufﬁcient to induce mitochondrial ROS generation. In patch
clamped guinea-pig cardiomyocytes, elevation of cytosolic Na+ from 5
to 15 mmol/L resulted in mitochondrial Ca2+ extrusion with a concur-
rent increase in H2O2 generation, effects which were blocked by the
mitochondrial Na+–Ca2+ exchange inhibitor CGP-37157 [7]. These
authors [7] suggest that Na+ overload promotes mitochondrial Ca2+
efﬂux, resulting in H2O2 accumulation as a consequence of impaired
NADPH-dependent mitochondrial antioxidant capacity. In our
study, using permeabilized myocytes, we conﬁrmed that Na+ over-
load can increase mitochondrial ROS production (Supplemental
Fig. 5) and that Na+-induced Ca2+ mishandling is attenuated by
CGP-37157 (Fig. 3C), in agreement with Kohlhaas et al. [7]. Involve-
ment of the mitochondrial Na+–Ca2+exchanger in this mechanism
assumes that mitochondrial Na+ and Ca2+ concentrations should
be altered by cytosolic Na+ overload. Changes in either Na+ or
Ca2+ concentration can induce mitochondrial dysfunction. Reduc-
tion of mitochondrial Ca2+ efﬂux in Na+-overloaded myocytes
may explain effect of ranolazine (which can reduce INaL and the
cytosolic Na+ concentration [19,20] and can indirectly increase the
activity of mitochondrial dehydrogenases such as pyruvate dehydro-
genase that rely on mitochondrial Ca2+ for their activity [35,36]).
However, it should be noted that the mechanisms of increased mito-
chondrial ROS generation are only partially understood.
4.3. Elevation of [Na+]i, CaMKII oxidation and phosphorylation, and their
relationship to disruption of Ca2+ handling
A novel observation in this study was that CaMKII oxidation was
increased subsequent to an elevation by ATX-II of the intracellular
Na+ concentration in intact cardiomyocytes (Fig. 2C, D) and TAC cardiac
tissue (Fig. 4B). ATX-II-induced CaMKII oxidationwas detected using an
antibody that speciﬁcally recognizes the oxidized methionine 281/282
site on CaMKII [30]. In parallel to the increase in oxidized-CaMKII, we
observed an ATX-II-induced increase in CaMKII phosphorylation at
Thr287, demonstrating increased autophosphorylation (Fig. 2C, D).
These results are in agreement with previous studies demonstrating
that CaMKII oxidation is accompanied by an increase in CaMKII
autophosphorylation [11,30,31]. Importantly, the increases in CaMKII
oxidation and phosphorylation were accompanied by an elevation in
the phosphorylation of CaMKII substrates involved in Ca2+ handling, in-
cluding PLN and RyR2 (Fig. 2C, D), demonstrating functional activation
of CaMKII. The ATX-II-induced oxidation/phosphorylation of CaMKII
and its substrates was attenuated by inhibitors of INaL, antioxidants
(DTT or CoQ10), or the CaMKII inhibitor KN-93. Treatment of myocytes
with KN-93 or CoQ10 restored normal Ca2+ dynamics and attenuated
arrhythmic activity in the presence of ATX-II (Fig. 2B). Similarly,KN-93 and CoQ10 also prevented aberrant Ca2+ handling induced by
elevated cytosolic Na+ in permeabilized cardiomyocytes (Fig. 3).
Furthermore, treatment of permeabilized cells with exogenous, pre-
activated phosphorylated CaMKII accelerated the frequency of sponta-
neous Ca2+ waves and increased diastolic Ca2+ (Supplemental Fig. 3).
The effects of pre-activated CaMKII were strikingly similar to those
observed after elevation of the intracellular Na+ concentration in
permeabilized myocytes (Fig. 3). Taken together, our data provide evi-
dence that CaMKII activity is both necessary and sufﬁcient to induce
maladaptive Ca2+ handling in cardiomyocytes, and it acts as both a
sensor for, and an effector of responses to, an increase in ROSproduction
[11,30,31].
A high level of oxidized CaMKIIδ has been associatedwith disruption
of intracellular Ca2+ handling, arrhythmias, and contractile dysfunction
[18,30,31,37–39]. Recently, Wagner et al. [18] demonstrated that ROS-
activated CaMKII is required for INaL augmentation leading to cellular
Na+ and Ca2+ overload. CaMKII can phosphorylate the cardiac Na+
channel pore-forming alpha subunit and enhance INaL [13,18,40]. Thus,
intracellular Na+-dependent activation of CaMKII could induce further
activation of INaL by a positive feedback mechanism. Moreover, CaMKII
alters Ca2+ handling in cardiac myocytes via phosphorylation of RyR2
and phospholamban to increase Ca2+ release from, and Ca2+ loading
of, the sarcoplasmic reticulum [41]. Theﬁnding that oxidation andphos-
phorylation of CaMKII were increased in myocytes exposed to the INaL
enhancer ATX-II is in accord with previous reports [12]. Thus, CaMKII
activation, including activation through an oxidation-dependent
pathway, is a key element in a complex interplay between Na+ load
and Ca2+ handling under pathological conditions [12,17,18,31,38,39].4.4. TAC data and relevance to heart failure
Increases of INaL and CaMKII activity are well documented in
cardiomyocytes isolated from failing hearts of experimental animals
[5,17,20,42] and human patients [20,42]. Toischer et al. recently report-
ed roles for INaL and CaMKII in the progression of pressure-overload
induced heart disease after TAC in mice [29]. In their study, INaL was
not enhanced during the compensatory hypertrophy stage (1 week
post-TAC) but was signiﬁcantly enhanced in hearts that had developed
heart failure (5 weeks post-TAC) characterized by a reduced ejection
fraction. In parallel to the increase in INaL observed in failing myocytes,
there was a signiﬁcant increase in both CaMKII autophosphorylation
and phosphorylation of NaV1.5 at the CaMKII site ser-571, when com-
pared to myocytes isolated from non-failing hearts or from hearts in
the compensatory hypertrophy stage [29]. In the present study, we
utilized a similar model of pressure overload-induced heart failure in
mice to examine the contributions of INaL, CaMKII and ROS to maladap-
tive Ca2+ handling in the failing heart. Heart failure was induced
by 4 weeks TAC, as evidenced by a signiﬁcant reduction in fractional
shortening of left ventricular myocardium, relative to sham-operated
mice (Fig. 4A). Importantly, the level of ox-CaMKII was increased in
cardiac tissue of TAC animals relative to sham animals (Fig. 4B).
Cardiomyocytes isolated from failing hearts had evidence of maladap-
tive Ca2+ handling, manifested as an increase in spontaneous Ca2+
release events (Fig. 4D). The frequency of Ca2+ release events was nor-
malized after treatment of myocytes with INaL inhibitor ranolazine or
CaMKII inhibitor KN-93. Treatment with ranolazine, KN-93 or CoQ10
all reduced cellular Na+, whereas ROS was reduced by either CoQ10
or ranolazine, but not by KN-93, because elevation of ROS production
can occur in the absence of CaMKII activation (Fig. 5). None of these
agents had an effect on the cytosolic Na+ concentration or on ROS pro-
duction in myocytes isolated from non-failing hearts (Supplemental
Fig. 6). Taken together with the work of Toischer et al. [29] our ﬁndings
suggest that INaL-induced Na+ overload, oxidative stress, and CaMKII
activity likely contribute to pro-arrhythmic Ca2+ mishandling in the
failing heart.
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Our results provide experimental evidence that CaMKIIδ oxidation
subsequent to mitochondrial ROS generations induced by cytosolic
Na+ overload is an important component of an intracellular signaling
pathway (Fig. 5) leading to aberrant Ca2+ handling under pathologic
conditions such as heart failure. This pathway is not dependent on,
but may operate in parallel with, the “classical” mechanism of Na+-
induced Ca2+ overload mediated by the sarcolemmal Na+–Ca2+
exchanger. The evidence that Na+ overload-induced mitochondrial
ROS formation and CaMKII oxidation are mechanisms of potential
importance in the etiology of cardiac disease may provide a conceptual
framework for the development of new drug therapies.
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